Estados financieros detallados de Kiora Pharmaceuticals, Inc. (KPRX): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Márgenes de los últimos 12 meses: margen bruto 0.0%, margen operativo 0.0%, margen neto 0.0%.
Al precio actual de $2.60, KPRX presenta beneficios negativos (P/E no significativo) y un ROE del -63.39%. La capitalización bursátil es de $12M.
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | $669259 | $407518 | $1.7M | $2.7M | $12059 | 0 | 0 | 0 | $16.0M | 0 |
| Coste de Ventas | $8.4M | $10.3M | $8.1M | $4889 | $3.3M | 0 | 0 | 0 | 0 | $24801 |
| Beneficio Bruto | -$7.8M | -$9.9M | -$6.4M | $2.7M | -$3.3M | 0 | 0 | 0 | $16.0M | -$24801 |
| I+D | $8.4M | $10.3M | $8.1M | $5.4M | $3.6M | $5.4M | $3.4M | $4.0M | $4.9M | $10.8M |
| Generales y Administrativos | $5.6M | $4.6M | $4.4M | $4.4M | $4.2M | $5.3M | $8.3M | $4.7M | $5.5M | $5.7M |
| Gastos Operativos | $14.0M | $15.0M | $12.5M | $9.8M | $3.6M | $14.2M | $12.3M | $12.6M | $11.5M | $9.4M |
| Beneficio Operativo | -$13.3M | -$14.6M | -$10.8M | -$7.0M | -$6.9M | -$14.2M | -$12.3M | -$12.6M | $4.5M | -$9.5M |
| EBITDA | -$13.3M | -$14.5M | -$10.7M | -$6.8M | -$7.5M | -$13.9M | -$13.6M | -$12.4M | $5.7M | -$12.1M |
| Gastos por Intereses | $275 | $1215 | $1040 | $325 | $4186 | $6851 | $8599 | $11132 | $21446 | $19960 |
| Beneficio Antes de Impuestos | -$13.3M | -$14.6M | -$10.7M | -$7.0M | -$6.8M | -$14.0M | -$13.7M | -$12.4M | $5.7M | -$12.1M |
| Impuestos | $3684 | -$1.3M | $86045 | $95396 | $12055 | -$192603 | -$113010 | $90319 | $2.1M | -$1.3M |
| Beneficio Neto | -$13.3M | -$13.2M | -$10.8M | -$7.1M | -$6.9M | -$13.8M | -$13.6M | -$12.5M | $3.6M | -$10.8M |
| BPA | $-906.30 | $-556.17 | $-182.81 | $-89.24 | $-70.50 | $-68.00 | $-18.55 | $-24.25 | $0.93 | $-2.64 |
| BPA Diluido | $-906.30 | $-556.17 | $-182.81 | $-89.24 | $-70.50 | $-68.00 | $-18.55 | $-24.25 | $0.87 | $-2.64 |
| Acciones en Circulación (Diluidas) | $14723 | $23766 | $59139 | $79525 | $114787 | $241099 | $732303 | $538007 | $4.1M | $4.1M |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $3.6M | $7.8M | $8.0M | $3.8M | $1.2M | $7.9M | $6.0M | $2.5M | $3.8M | $8.7M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $23.0M | $8.4M |
| Cuentas por Cobrar | $53833 | $23685 | $18436 | $4857 | $90975 | $529560 | $1.4M | $2.0M | $601197 | $3.3M |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $4.2M | $8.5M | $8.5M | $4.3M | $1.7M | $9.0M | $7.7M | $4.7M | $29.7M | $21.7M |
| Inmovilizado Material | $38040 | $55751 | $43518 | $16846 | $114494 | $283410 | $172169 | $114954 | $62402 | $377499 |
| Fondo de Comercio | $5.4M | 0 | $1.5M | $1.5M | $3.6M | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | $5.4M | $4.2M | $4.1M | $9.7M | $10.8M | $10.7M | $8.8M | $6.7M | $2.1M |
| Activos Totales | $9.7M | $14.3M | $14.3M | $10.1M | $15.3M | $20.1M | $18.7M | $13.7M | $36.5M | $24.3M |
| Cuentas por Pagar | $1.4M | $706089 | $63654 | $210289 | $434763 | $160621 | $1.0M | $206260 | $415590 | $1.1M |
| Deuda a Corto | 0 | 0 | 0 | 0 | $212281 | 0 | 0 | $47069 | 0 | $164461 |
| Pasivos Corrientes | $7.3M | $14.8M | $3.9M | $1.4M | $2.0M | $1.6M | $3.3M | $1.6M | $6.0M | $3.6M |
| Deuda a Largo | 0 | 0 | 0 | 0 | $278190 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $10.1M | $16.2M | $5.3M | $3.5M | $5.6M | $5.6M | $7.3M | $7.6M | $10.7M | $8.1M |
| Reservas | -$78.6M | -$91.8M | -$93.2M | -$100.2M | -$107.1M | -$120.9M | -$134.5M | -$147.0M | -$143.4M | -$154.2M |
| Patrimonio Neto | -$329421 | -$1.9M | $8.9M | $6.6M | $9.7M | $14.6M | $11.4M | $6.1M | $25.8M | $16.1M |
| Deuda Total | $28714 | $16069 | $4715 | $83926 | $574399 | $209412 | $105782 | $106891 | $57170 | $368259 |
| Deuda Neta | -$3.6M | -$7.8M | -$8.0M | -$3.7M | -$611278 | -$7.6M | -$5.9M | -$2.3M | -$26.7M | -$16.7M |
| Capital Circulante | -$3.2M | -$6.4M | $4.6M | $2.9M | -$258387 | $7.4M | $4.4M | $3.1M | $23.7M | $18.1M |
Flujo de Caja (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Beneficio Neto | -$13.3M | -$13.2M | -$10.8M | -$7.1M | -$6.9M | -$13.8M | -$13.6M | -$12.5M | $3.6M | -$10.8M |
| Amortizaciones | $5185 | $19288 | $38483 | $213933 | $33399 | $45296 | $41609 | $51798 | $19205 | $24801 |
| Compensación en Acciones | $510995 | $870308 | $875287 | $852230 | $723856 | $842475 | $462450 | $754944 | $656593 | $900236 |
| Cambio en Capital Circulante | $4.4M | $7.1M | -$1.0M | -$192542 | -$321209 | -$1.0M | $668513 | -$1.8M | $3.7M | -$3.3M |
| Flujo de Caja Operativo | -$8.4M | -$6.5M | -$10.8M | -$8.2M | -$7.3M | -$10.7M | -$10.4M | -$9.6M | $8.6M | -$10.0M |
| Inversiones (CapEx) | -$11000 | -$36999 | -$270000 | 0 | -$20077 | -$63865 | 0 | 0 | -$6256 | -$110789 |
| Adquisiciones | $185746 | 0 | 0 | 0 | -$224361 | -$93155 | 0 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | -$2614 | 0 | 0 | -$15629 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$8.4M | -$6.5M | -$11.1M | -$8.2M | -$7.3M | -$10.7M | -$10.4M | -$9.6M | $8.6M | -$10.1M |
Crecimiento y Márgenes (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Crecimiento Ingresos (anual) | -39.1% | +305.5% | +62.5% | -99.6% | -100.0% | -100.0% | ||||
| Crecimiento Beneficio Neto (anual) | +0.9% | +18.2% | +34.4% | +3.3% | -100.7% | +1.4% | +7.9% | +128.7% | -401.4% | |
| Crecimiento BPA (anual) | +38.6% | +67.1% | +51.2% | +21.0% | +3.5% | +72.7% | -30.7% | +103.8% | -383.9% | |
| Cambio en Acciones (anual) | +61.4% | +148.8% | +34.5% | +44.3% | +110.0% | +203.7% | -26.5% | +666.7% | -0.5% | |
| Crecimiento FCF (anual) | +22.8% | -70.8% | +26.6% | +10.0% | -46.4% | +2.9% | +8.4% | +189.5% | -217.8% | |
| Margen Bruto | -1158.5% | -2434.9% | -387.5% | 99.8% | -27038.7% | 100.0% | ||||
| Margen Operativo | -1994.3% | -3572.7% | -656.3% | -260.6% | -56960.5% | 28.2% | ||||
| Margen EBITDA | -1992.9% | -3567.8% | -646.6% | -252.7% | -61961.7% | 35.6% | ||||
| Margen Neto | -1993.8% | -3243.5% | -654.2% | -264.2% | -56901.7% | 22.5% | ||||
| Margen FCF | -1258.7% | -1596.4% | -672.6% | -303.6% | -60844.6% | 53.5% | ||||
| Tasa Impositiva Efectiva | -0.0% | 9.2% | -0.8% | -1.4% | -0.2% | 1.4% | 0.8% | -0.7% | 36.5% | 10.6% |
Datos por Acción (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| FCF por Acción | $-572.18 | $-273.73 | $-187.94 | $-102.53 | $-63.92 | $-44.54 | $-14.24 | $-17.76 | $2.07 | $-2.45 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $14723 | $23766 | $59139 | $79525 | $114787 | $241099 | $732303 | $538007 | $3.9M | $4.1M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -63.39% |
| Rentabilidad sobre capital invertido | -53.16% |
| Rentabilidad sobre activos | -46.21% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Salud financiera
| Deuda / Patrimonio | 0.02 |
| Ratio corriente | 8.97 |
Ratios Clave (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E | -9.71 | -10.39 | -13.74 | -40.42 | -25.17 | -7.99 | -1.66 | -0.19 | 3.55 | -0.75 |
| P/VC | -393.39 | -71.26 | 16.62 | 43.32 | 20.94 | 8.99 | 1.98 | 0.41 | 0.50 | 0.50 |
| P/V | 193.63 | 336.97 | 89.88 | 106.80 | 16893.94 | 0.00 | 0.00 | 0.00 | 0.80 | 0.00 |
| Margen Bruto | -1158.5% | -2434.9% | -387.5% | 99.8% | -27038.7% | 0.0% | 0.0% | 0.0% | 100.0% | 0.0% |
| Margen Operativo | -1994.3% | -3572.7% | -656.3% | -260.6% | -56960.5% | 0.0% | 0.0% | 0.0% | 28.2% | 0.0% |
| Margen Neto | -1993.8% | -3243.5% | -654.2% | -264.2% | -56901.7% | 0.0% | 0.0% | 0.0% | 22.5% | 0.0% |
Empresas relacionadas: ACXP · ADIL · APRE · APVO · BCDA · CELZ · HCWB
Explorar sector: Healthcare · Biotechnology
Más secciones de KPRX: Resumen · Valoración · Estadísticas · Estimaciones · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones